Delivery Order SPE2DB25D3109-SPE2DB26FP4PX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,664.45 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCZ 320-25 mg tablets (90-count) on November 4, 2025, with completion expected by November 5, 2025. This competitively awarded, non-set-aside contract features firm fixed pricing and is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is located. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $20,474.63 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCtz 320-25 mg tablets (90-count units) on April 21, 2025, with an ultimate completion date of April 22, 2025. The contract employs firm fixed pricing and was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with...
- The Defense Logistics Agency awarded a $3,819.87 delivery order to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-12.5 mg tablets (90-count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency awarded a $3,084.13 delivery order to AmerisourceBergen Drug Corp for Valsartan-HCT 320-25 mg tablets (90-count units) with an ultimate completion date of June 3, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $7,383.75 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCZ 320-25 mg tablets (90-count) on November 3, 2025, with completion scheduled for November 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $9,611.56 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCZ 320-25 mg tablets (90-count) on May 6, 2025, with completion scheduled for May 7, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,362.54 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 320-25 mg tablets (90-count) on August 18, 2025, with completion expected by August 19, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under an open contracting vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $1,067.90 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-25 mg tablets (90-count packaging). The contract was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, utilizing firm fixed-price terms with no set-aside designation. Performance will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order valued at $2,768.94 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCZ 160-25 mg tablets in quantities of 90 per unit. This competitively awarded, non-set-aside contract employs firm fixed price terms with an ultimate completion date of August 22, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,182.88 to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Valsartan-HCZ 160-25 mg tablets in a quantity of 90 units. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 4, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical...
- SPE2DB25D3109Indefinite Delivery Contract
- SPE2DB25D3109-SPE2DB26FP4PXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,206.20 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCtz 320-25 mg tablets (90-count units). This competitive award, issued on November 4, 2025, with an ultimate completion date of November 5, 2025, reflects a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a critical vendor within the Defense Logistics Agency's Medical Supply Chain, AmerisourceBergen demonstrates substantial capability in fulfilling federal procurement requirements through open competition. The company's federal contract portfolio encompasses medications across multiple therapeutic domains, including specialty pharmaceuticals, generic drugs, vaccines, and related medical supplies, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 11/4/25 |